Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Privileged structures: applications in drug discovery.

R W DeSimone1, K S Currie, S A Mitchell

  • 1Cellular Genomics Inc. 36 East Industrial Rd Branford, CT 06405, USA. robd@cellulargenomics.com

Combinatorial Chemistry & High Throughput Screening
|August 24, 2004
PubMed
Summary

The privileged structure concept aids in discovering new biologically active molecules. Understanding structure-target relationships optimizes drug discovery and development for various biological targets.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient experience and burden of haemolytic disease of the foetus and newborn: a systematic review.

BMC pregnancy and childbirth·2025
Same author

Matching plus regression adjustment for the estimation of the average treatment effect on survival outcomes: a case study with mosunetuzumab in relapsed/refractory follicular lymphoma.

BMC medical research methodology·2025
Same author

Systematic review of the patient burden of generalised myasthenia gravis in Europe, the Middle East, and Africa.

BMC neurology·2024
Same author

Reliability and validity of PRO-CTCAE® daily reporting with a 24-hour recall period.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2023
Same author

Linguistic validation of the simplified Chinese version of the US National Cancer Institute's patient-reported outcomes version of the common terminology criteria for adverse events (PRO-CTCAE™).

BMC cancer·2020
Same author

Cancer survivor perspectives on sharing patient-generated health data with central cancer registries.

Quality of life research : an international journal of quality of life aspects of treatment, care and rehabilitation·2019

Area of Science:

  • Medicinal Chemistry
  • Drug Discovery
  • Computational Chemistry

Background:

  • The privileged structure concept has gained prominence in discovering novel biologically active molecules over the last 15 years.
  • Privileged structures are versatile molecular scaffolds capable of binding to multiple biological targets through functional group modifications.
  • These structures possess favorable drug-like properties, enhancing compound libraries and lead generation.

Purpose of the Study:

  • To discuss the identification and importance of privileged structures in drug discovery.
  • To emphasize understanding structure-target relationships for conferring "privileged" status.
  • To illustrate the application of privileged structures in traditional medicinal chemistry and focused library design.

Main Methods:

Related Experiment Videos

  • Identification of privileged structures based on versatile binding properties.
  • Analysis of structure-target relationships to understand "privileged" status.
  • Application of privileged structure-based libraries for distinct target families (GPCRs, LGICs, enzymes/kinases).

Main Results:

  • Privileged structures facilitate the discovery of potent and selective ligands for diverse biological targets.
  • Compounds derived from privileged structures exhibit improved drug-like properties.
  • Successful exploitation across and within different target families has been demonstrated.

Conclusions:

  • The privileged structure approach is effective for discovering and optimizing novel bioactive molecules.
  • Understanding structure-target relationships is key to leveraging privileged structures.
  • This strategy provides a solid foundation for high-quality lead development in medicinal chemistry.